Methuselah Foundation Unveils ELONgevity Protection to Support Human Longevity Initiatives, Provide Access to Promising Experimental Therapies

Dogelon Mars (ELON) will be the key for terminally ill participants to unlock investigational treatments that offer a fighting chance to overcome deadly diseases Methuselah Foundation Co-founder and CEO David Gobel announced the formation of the ELONgevity Protection Project to promote human anti-aging efforts and provide members diagnosed with terminal diseases access to experimental therapies […]

thaipr.net

21 ก.ย. 65

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in China The deal brings together Melinta’s innovation, Menarini’s cross-regional expertise in registration and marketing this asset, and SciClone’s development and commercial presence in China Menarini will receive a total payment of up to […]

thaipr.net

20 ก.ย. 65

MagicTouch SCB receives IDE approval for In-Stent Restenosis indication

The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR). US FDA’s IDE approval allows the MagicTouch SCB to be used in a pivotal clinical study to support safety and effectiveness of this combination product. The data generated from this IDE clinical study will support a pre-market […]

thaipr.net

20 ก.ย. 65
1 58 59 60 61 62 128